Literature DB >> 8290470

Determination of acrolein in urine by liquid chromatography and fluorescence detection of its quinoline derivative.

S al-Rawithi1, A el-Yazigi, P J Nicholls.   

Abstract

We describe an assay for acrolein in urine, employing derivatization with m-aminophenol in the presence of ferrous sulfate solution in sulfuric acid. The derivative (7-OH quinoline; DER) and the internal standard (quinine-bisulfate; IS) were separated on a 10-micron particle, 8 mm x 10-cm C18 cartridge in conjunction with a radial compression system using a mixture of 0.05 M dibasic ammonium phosphate solution (pH 2.5):acetonitrile:methanol (92:6:2) at a flow rate of 3 mL/min as a mobile phase. The effluent was monitored fluorometrically at excitation and emission wavelengths of 360 and 495 nm, respectively. The retention times of DER and IS under these conditions were 4.3 and 26 min, respectively, and no interference in the assay from any endogenous substance or other concomitantly used drug was observed. The assay was highly linear (r > 0.994) in the range 1-20 micrograms/mL of acrolein in urine (CV at different concentrations, < or = 7.9%). This method can serve to monitor acrolein pharmacokinetics in patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8290470     DOI: 10.1023/a:1018964401677

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  3 in total

1.  Fluorometric determination of acrolein and related compounds with m-aminophenol.

Authors:  R A Alarcon
Journal:  Anal Chem       Date:  1968-09       Impact factor: 6.986

2.  Clinical pharmacology of anticancer drugs.

Authors:  B A Chabner; C E Myers; V T Oliverio
Journal:  Semin Oncol       Date:  1977-06       Impact factor: 4.929

3.  Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention.

Authors:  J Cannon; C A Linke; L R Cos
Journal:  Urology       Date:  1991-11       Impact factor: 2.649

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.